hu.MAP 2.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: HuMAP2_04684
Confidence: High
Proteins| Genename | Protein Name | Links |
|---|---|---|
| AKAP9 | A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao) | UniProt NCBI |
| PRKAR1A | cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1) | UniProt NCBI |
| PRKAR2A | cAMP-dependent protein kinase type II-alpha regulatory subunit | UniProt NCBI |
| AKAP11 | A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11) | UniProt NCBI |
| PRKACA | cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) | UniProt NCBI |
| AKAP5 | A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 79 kDa) (AKAP 79) (H21) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein) | UniProt NCBI |
| PRKACG | cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11) | UniProt NCBI |
| PRKAR2B | cAMP-dependent protein kinase type II-beta regulatory subunit | UniProt NCBI |
| PRKACB | cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11) | UniProt NCBI |
| PRKAR1B | cAMP-dependent protein kinase type I-beta regulatory subunit | UniProt NCBI |
Enrichments
| Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
|---|---|---|---|---|
| WP:WP35 | 1.69215830009e-21 | 1.0 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKAR2A AKAP11 AKAP9 PRKACA PRKACG | G Protein Signaling Pathways |
| REAC:R-HSA-442720 | 2.56994862106e-19 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | CREB1 phosphorylation through the activation of Adenylate Cyclase |
| REAC:R-HSA-381676 | 3.6843317154e-18 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Glucagon-like Peptide-1 (GLP1) regulates insulin secretion |
| REAC:R-HSA-163615 | 8.90130062537e-18 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | PKA activation |
| REAC:R-HSA-164378 | 1.51295414582e-17 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | PKA activation in glucagon signalling |
| REAC:R-HSA-111931 | 2.47530635545e-17 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | PKA-mediated phosphorylation of CREB |
| WP:WP2012 | 1.52447482786e-16 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | miRs in Muscle Cell Differentiation |
| REAC:R-HSA-180024 | 1.9051767808e-16 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | DARPP-32 events |
| WP:WP3965 | 2.74308599139e-16 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Lipid Metabolism Pathway |
| REAC:R-HSA-422356 | 1.30359620994e-15 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Regulation of insulin secretion |
| REAC:R-HSA-163359 | 2.04062490031e-15 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Glucagon signaling in metabolic regulation |
| REAC:R-HSA-111997 | 3.31405994013e-15 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | CaM pathway |
| REAC:R-HSA-111933 | 3.31405994013e-15 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Calmodulin induced events |
| GO:0071377 | 3.6159604085e-15 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | cellular response to glucagon stimulus |
| GO:0034199 | 3.6159604085e-15 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | activation of protein kinase A activity |
| GO:0051018 | 4.4122148445e-15 | 0.8 | PRKAR2B AKAP5 PRKAR1A PRKAR1B PRKAR2A AKAP11 AKAP9 PRKACA | protein kinase A binding |
| REAC:R-HSA-111996 | 5.21473355565e-15 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Ca-dependent events |
| REAC:R-HSA-432040 | 7.98111697869e-15 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Vasopressin regulates renal water homeostasis via Aquaporins |
| GO:0033762 | 9.36531910293e-15 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | response to glucagon |
| REAC:R-HSA-1489509 | 1.19191907768e-14 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | DAG and IP3 signaling |
| REAC:R-HSA-445717 | 1.19191907768e-14 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Aquaporin-mediated transport |
| REAC:R-HSA-163685 | 2.24559346109e-14 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Integration of energy metabolism |
| WP:WP3869 | 8.70263699402e-14 | 0.6 | PRKAR2B PRKAR1A PRKAR1B PRKACB PRKACG PRKACA | Cannabinoid receptor signaling |
| REAC:R-HSA-112043 | 8.95278499642e-14 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | PLC beta mediated events |
| REAC:R-HSA-112040 | 1.03436116672e-13 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | G-protein mediated events |
| GO:0097546 | 1.22110433711e-13 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | ciliary base |
| GO:0003091 | 2.89581343455e-13 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | renal water homeostasis |
| REAC:R-HSA-9010642 | 4.83294786212e-13 | 0.5 | AKAP5 PRKACB PRKACG PRKACA PRKAR2A | ROBO receptors bind AKAP5 |
| REAC:R-HSA-438064 | 1.25506693799e-12 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Post NMDA receptor activation events |
| WP:WP4540 | 1.33968892631e-12 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Pathways Regulating Hippo Signaling |
| REAC:R-HSA-112314 | 2.85501532469e-12 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Neurotransmitter receptors and postsynaptic signal transmission |
| REAC:R-HSA-442755 | 3.4821254551e-12 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Activation of NMDA receptors and postsynaptic events |
| REAC:R-HSA-111885 | 4.12939329332e-12 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Opioid Signalling |
| WP:WP4541 | 4.22262367441e-12 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Hippo-Merlin Signaling Dysregulation |
| KEGG:04910 | 1.3986010241e-11 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Insulin signaling pathway |
| GO:0050891 | 1.84635552067e-11 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | multicellular organismal water homeostasis |
| REAC:R-HSA-112315 | 2.36110356683e-11 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Transmission across Chemical Synapses |
| GO:0030104 | 2.47212318845e-11 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | water homeostasis |
| REAC:R-HSA-5610787 | 2.59862072753e-11 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Hedgehog 'off' state |
| GO:0003014 | 1.28349369179e-10 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | renal system process |
| REAC:R-HSA-5358351 | 1.51250412462e-10 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Signaling by Hedgehog |
| REAC:R-HSA-983231 | 3.38234105184e-10 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Factors involved in megakaryocyte development and platelet production |
| REAC:R-HSA-112316 | 6.29762526821e-10 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Neuronal System |
| WP:WP536 | 3.07921636635e-09 | 0.6 | PRKAR2B PRKAR1A PRKAR1B PRKACB PRKAR2A PRKACA | Calcium Regulation in the Cardiac Cell |
| WP:WP706 | 4.56356285029e-09 | 0.6 | PRKAR2B PRKAR1A PRKAR1B PRKACB PRKAR2A PRKACA | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways |
| WP:WP289 | 5.25496107597e-09 | 0.6 | PRKAR2B PRKAR1A PRKAR1B PRKACB PRKAR2A PRKACA | Myometrial Relaxation and Contraction Pathways |
| REAC:R-HSA-418594 | 1.12444684408e-08 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | G alpha (i) signalling events |
| REAC:R-HSA-9006925 | 1.18647995011e-08 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Intracellular signaling by second messengers |
| CORUM:878 | 1.62176028613e-08 | 0.3 | PRKAR2B PRKAR2A AKAP5 | PKA (RII-alpha and RII-beta)-AKAP5-ADRB1 complex |
| CORUM:520 | 6.48475406063e-08 | 0.3 | AKAP9 PRKAR2A PRKACA | KCNQ1 macromolecular complex |
| GO:2000480 | 7.67964804112e-08 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | negative regulation of cAMP-dependent protein kinase activity |
| GO:0008603 | 7.67964804112e-08 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | cAMP-dependent protein kinase regulator activity |
| GO:0004862 | 7.67964804112e-08 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | cAMP-dependent protein kinase inhibitor activity |
| GO:0005952 | 1.79134017731e-07 | 0.4 | PRKAR1B PRKACB PRKAR2A PRKACA | cAMP-dependent protein kinase complex |
| GO:0071417 | 3.02869622435e-07 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | cellular response to organonitrogen compound |
| GO:0071375 | 3.43678784348e-07 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | cellular response to peptide hormone stimulus |
| REAC:R-HSA-163358 | 4.55671370693e-07 | 0.3 | PRKACB PRKACG PRKACA | PKA-mediated phosphorylation of key metabolic factors |
| GO:1901699 | 7.28526953098e-07 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | cellular response to nitrogen compound |
| GO:0043434 | 8.06048946738e-07 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | response to peptide hormone |
| GO:0032147 | 9.44565726577e-07 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | activation of protein kinase activity |
| GO:0034236 | 1.07376483024e-06 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | protein kinase A catalytic subunit binding |
| GO:2000479 | 1.07376483024e-06 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | regulation of cAMP-dependent protein kinase activity |
| GO:1901653 | 1.20849302548e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | cellular response to peptide |
| REAC:R-HSA-8963896 | 1.59372534406e-06 | 0.3 | PRKACB PRKACG PRKACA | HDL assembly |
| GO:0047555 | 1.68680065522e-06 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | 3',5'-cyclic-GMP phosphodiesterase activity |
| REAC:R-HSA-109582 | 1.71878324538e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Hemostasis |
| REAC:R-HSA-388396 | 1.76380008137e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | GPCR downstream signalling |
| GO:0007596 | 2.76070647464e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | blood coagulation |
| GO:0007599 | 2.91240247359e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | hemostasis |
| GO:0050817 | 2.99088584838e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | coagulation |
| REAC:R-HSA-372790 | 3.11581510909e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Signaling by GPCR |
| GO:1901652 | 3.23728339391e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | response to peptide |
| REAC:R-HSA-382551 | 3.84504640568e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Transport of small molecules |
| WP:WP2436 | 3.87755365499e-06 | 0.3 | PRKACB PRKACG PRKACA | Dopamine metabolism |
| GO:0048871 | 5.11181727015e-06 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | multicellular organismal homeostasis |
| GO:0010243 | 5.56076185522e-06 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | response to organonitrogen compound |
| REAC:R-HSA-9634600 | 1.00000521116e-05 | 0.3 | PRKACB PRKACG PRKACA | Regulation of glycolysis by fructose 2,6-bisphosphate metabolism |
| REAC:R-HSA-392517 | 1.00000521116e-05 | 0.3 | PRKACB PRKACG PRKACA | Rap1 signalling |
| GO:0044441 | 1.36540613426e-05 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | ciliary part |
| GO:0050878 | 1.36540613426e-05 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | regulation of body fluid levels |
| GO:1901698 | 1.40694797488e-05 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | response to nitrogen compound |
| GO:0019934 | 1.97611812398e-05 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | cGMP-mediated signaling |
| REAC:R-HSA-8963898 | 2.06600520876e-05 | 0.3 | PRKACB PRKACG PRKACA | Plasma lipoprotein assembly |
| GO:0045860 | 2.23536762398e-05 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | positive regulation of protein kinase activity |
| GO:0044093 | 2.61891971529e-05 | 0.9 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | positive regulation of molecular function |
| REAC:R-HSA-376176 | 2.83894774543e-05 | 0.5 | AKAP5 PRKACB PRKACG PRKACA PRKAR2A | Signaling by ROBO receptors |
| GO:1901701 | 2.93114862175e-05 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | cellular response to oxygen-containing compound |
| GO:0004114 | 3.0493905917e-05 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | 3',5'-cyclic-nucleotide phosphodiesterase activity |
| GO:0042060 | 3.41160845926e-05 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | wound healing |
| GO:0001934 | 3.67525671256e-05 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | positive regulation of protein phosphorylation |
| GO:0004112 | 3.72583061524e-05 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | cyclic-nucleotide phosphodiesterase activity |
| KEGG:05020 | 3.79409258582e-05 | 0.3 | PRKACB PRKACG PRKACA | Prion diseases |
| GO:0033674 | 4.02653354495e-05 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | positive regulation of kinase activity |
| GO:0010737 | 4.50876096325e-05 | 0.4 | AKAP5 PRKACB PRKACG PRKACA | protein kinase A signaling |
| GO:0005929 | 5.94118978741e-05 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | cilium |
| GO:0042327 | 5.9935558155e-05 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | positive regulation of phosphorylation |
| REAC:R-HSA-5621575 | 6.0263228955e-05 | 0.3 | PRKACB PRKACG PRKACA | CD209 (DC-SIGN) signaling |
| GO:0032870 | 6.0440699317e-05 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | cellular response to hormone stimulus |
| REAC:R-HSA-163560 | 6.97538610278e-05 | 0.3 | PRKACB PRKACG PRKACA | Triglyceride catabolism |
| GO:0009611 | 7.40243571232e-05 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | response to wounding |
| GO:0030291 | 7.60482825515e-05 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | protein serine/threonine kinase inhibitor activity |
| KEGG:04913 | 8.73165203466e-05 | 0.3 | PRKACB PRKACG PRKACA | Ovarian steroidogenesis |
| GO:0010562 | 9.0141953331e-05 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | positive regulation of phosphorus metabolic process |
| GO:0045937 | 9.0141953331e-05 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | positive regulation of phosphate metabolic process |
| CORUM:4869 | 9.0534767973e-05 | 0.2 | AKAP5 PRKAR2A | beta(1)-AR receptosome (ADRB1-SAP97-AKAP79-PRKAR2A) |
| CORUM:517 | 9.0534767973e-05 | 0.2 | AKAP5 PRKAR2A | AKAP5-PRKAR2A-PPP3CA complex |
| KEGG:04962 | 0.000102190419105 | 0.3 | PRKACB PRKACG PRKACA | Vasopressin-regulated water reabsorption |
| GO:0120038 | 0.00010969621445 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | plasma membrane bounded cell projection part |
| GO:0044463 | 0.00010969621445 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | cell projection part |
| WP:WP2636 | 0.000113369764245 | 0.3 | PRKACB PRKACG PRKACA | Common Pathways Underlying Drug Addiction |
| WP:WP4249 | 0.000113369764245 | 0.3 | PRKACB PRKACG PRKACA | Hedgehog Signaling Pathway |
| GO:0051347 | 0.000121743414533 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | positive regulation of transferase activity |
| KEGG:04923 | 0.000136791504244 | 0.3 | PRKACB PRKACG PRKACA | Regulation of lipolysis in adipocytes |
| KEGG:04340 | 0.000136791504244 | 0.3 | PRKACB PRKACG PRKACA | Hedgehog signaling pathway |
| KEGG:05030 | 0.000156676930986 | 0.3 | PRKACB PRKACG PRKACA | Cocaine addiction |
| GO:1901700 | 0.000171381980684 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | response to oxygen-containing compound |
| GO:0009725 | 0.000172255300564 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | response to hormone |
| KEGG:05110 | 0.000178390726274 | 0.3 | PRKACB PRKACG PRKACA | Vibrio cholerae infection |
| GO:0043085 | 0.000185046890637 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | positive regulation of catalytic activity |
| KEGG:04961 | 0.000202011439131 | 0.3 | PRKACB PRKACG PRKACA | Endocrine and other factor-regulated calcium reabsorption |
| REAC:R-HSA-8853659 | 0.000202954173087 | 0.3 | PRKACB PRKACG PRKACA | RET signaling |
| GO:0031401 | 0.000217274296628 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | positive regulation of protein modification process |
| GO:0004691 | 0.000217734118711 | 0.3 | PRKACB PRKACG PRKACA | cAMP-dependent protein kinase activity |
| KEGG:04924 | 0.000241189244352 | 0.3 | PRKACB PRKACG PRKACA | Renin secretion |
| GO:0071495 | 0.00025196780675 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | cellular response to endogenous stimulus |
| REAC:R-HSA-8979227 | 0.000269898234756 | 0.3 | PRKACB PRKACG PRKACA | Triglyceride metabolism |
| KEGG:04213 | 0.000285097158672 | 0.3 | PRKACB PRKACG PRKACA | Longevity regulating pathway - multiple species |
| KEGG:04976 | 0.000285097158672 | 0.3 | PRKACB PRKACG PRKACA | Bile secretion |
| HP:0001580 | 0.000294015268291 | 0.2 | PRKACA PRKAR1A | Pigmented micronodular adrenocortical disease |
| KEGG:04927 | 0.000300829621613 | 0.3 | PRKACB PRKACG PRKACA | Cortisol synthesis and secretion |
| KEGG:04742 | 0.000317126481734 | 0.3 | PRKACB PRKACG PRKACA | Taste transduction |
| GO:0045859 | 0.000355704541453 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | regulation of protein kinase activity |
| KEGG:04971 | 0.000369500071094 | 0.3 | PRKACB PRKACG PRKACA | Gastric acid secretion |
| KEGG:04720 | 0.000388151075291 | 0.3 | PRKACB PRKACG PRKACA | Long-term potentiation |
| KEGG:05031 | 0.000388151075291 | 0.3 | PRKACB PRKACG PRKACA | Amphetamine addiction |
| GO:0003008 | 0.000421501385899 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | system process |
| REAC:R-HSA-1430728 | 0.000466695107701 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Metabolism |
| KEGG:04918 | 0.000513257270191 | 0.3 | PRKACB PRKACG PRKACA | Thyroid hormone synthesis |
| GO:0009719 | 0.000516535851005 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | response to endogenous stimulus |
| GO:0001932 | 0.000594669906052 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | regulation of protein phosphorylation |
| GO:0004690 | 0.000609225680053 | 0.3 | PRKACB PRKACG PRKACA | cyclic nucleotide-dependent protein kinase activity |
| KEGG:04911 | 0.000609933581564 | 0.3 | PRKACB PRKACG PRKACA | Insulin secretion |
| KEGG:04970 | 0.000662481583065 | 0.3 | PRKACB PRKACG PRKACA | Salivary secretion |
| GO:0043549 | 0.000693244101822 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | regulation of kinase activity |
| KEGG:04727 | 0.000806736588554 | 0.3 | PRKACB PRKACG PRKACA | GABAergic synapse |
| KEGG:04750 | 0.000869790061312 | 0.3 | PRKACB PRKACG PRKACA | Inflammatory mediator regulation of TRP channels |
| KEGG:04914 | 0.000869790061312 | 0.3 | PRKACB PRKACG PRKACA | Progesterone-mediated oocyte maturation |
| KEGG:05032 | 0.000869790061312 | 0.3 | PRKACB PRKACG PRKACA | Morphine addiction |
| KEGG:04912 | 0.000869790061312 | 0.3 | PRKACB PRKACG PRKACA | GnRH signaling pathway |
| HP:0001579 | 0.000881729914172 | 0.2 | PRKACA PRKAR1A | Primary hypercortisolism |
| HP:0000849 | 0.000881729914172 | 0.2 | PRKACA PRKAR1A | Adrenocortical abnormality |
| KEGG:04211 | 0.000902501015727 | 0.3 | PRKACB PRKACG PRKACA | Longevity regulating pathway |
| KEGG:04540 | 0.000970338030201 | 0.3 | PRKACB PRKACG PRKACA | Gap junction |
| KEGG:05414 | 0.00100548271655 | 0.3 | PRKACB PRKACG PRKACA | Dilated cardiomyopathy (DCM) |
| KEGG:05146 | 0.00100548271655 | 0.3 | PRKACB PRKACG PRKACA | Amoebiasis |
| KEGG:04925 | 0.00111593295957 | 0.3 | PRKACB PRKACG PRKACA | Aldosterone synthesis and secretion |
| KEGG:04713 | 0.00111593295957 | 0.3 | PRKACB PRKACG PRKACA | Circadian entrainment |
| KEGG:04916 | 0.00115445265122 | 0.3 | PRKACB PRKACG PRKACA | Melanogenesis |
| KEGG:01522 | 0.00119383922172 | 0.3 | PRKACB PRKACG PRKACA | Endocrine resistance |
| REAC:R-HSA-174824 | 0.00124059014652 | 0.3 | PRKACB PRKACG PRKACA | Plasma lipoprotein assembly, remodeling, and clearance |
| GO:0004860 | 0.00136562237441 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | protein kinase inhibitor activity |
| KEGG:04726 | 0.00140409759695 | 0.3 | PRKACB PRKACG PRKACA | Serotonergic synapse |
| KEGG:04725 | 0.0014488786522 | 0.3 | PRKACB PRKACG PRKACA | Cholinergic synapse |
| KEGG:04922 | 0.0014488786522 | 0.3 | PRKACB PRKACG PRKACA | Glucagon signaling pathway |
| REAC:R-HSA-5610780 | 0.00145337784533 | 0.3 | PRKACB PRKACG PRKACA | Degradation of GLI1 by the proteasome |
| GO:0042325 | 0.00149250127988 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | regulation of phosphorylation |
| KEGG:04928 | 0.00149459086207 | 0.3 | PRKACB PRKACG PRKACA | Parathyroid hormone synthesis, secretion and action |
| REAC:R-HSA-5610785 | 0.00152933113104 | 0.3 | PRKACB PRKACG PRKACA | GLI3 is processed to GLI3R by the proteasome |
| REAC:R-HSA-5610783 | 0.00152933113104 | 0.3 | PRKACB PRKACG PRKACA | Degradation of GLI2 by the proteasome |
| KEGG:04270 | 0.00158884524162 | 0.3 | PRKACB PRKACG PRKACA | Vascular smooth muscle contraction |
| KEGG:04724 | 0.00163740562511 | 0.3 | PRKACB PRKACG PRKACA | Glutamatergic synapse |
| GO:0034380 | 0.00179314168727 | 0.3 | PRKACB PRKACG PRKACA | high-density lipoprotein particle assembly |
| GO:0019210 | 0.0018503338385 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | kinase inhibitor activity |
| GO:0051338 | 0.00186779604489 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | regulation of transferase activity |
| KEGG:04114 | 0.00200492773446 | 0.3 | PRKACB PRKACG PRKACA | Oocyte meiosis |
| GO:0032270 | 0.00201520999718 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | positive regulation of cellular protein metabolic process |
| REAC:R-HSA-70171 | 0.00204073698337 | 0.3 | PRKACB PRKACG PRKACA | Glycolysis |
| WP:000000 | 0.00210673922044 | 1.0 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKAR2A AKAP11 AKAP9 PRKACA PRKACG | WIKIPATHWAYS |
| WP:WP4321 | 0.00212596985033 | 0.3 | PRKACB PRKACG PRKACA | Thermogenesis |
| REAC:R-HSA-380284 | 0.00213564188708 | 0.3 | AKAP9 PRKACA PRKAR2B | Loss of proteins required for interphase microtubule organization from the centrosome |
| REAC:R-HSA-380259 | 0.00213564188708 | 0.3 | AKAP9 PRKACA PRKAR2B | Loss of Nlp from mitotic centrosomes |
| REAC:R-HSA-422475 | 0.00217154062813 | 0.5 | AKAP5 PRKACB PRKACG PRKACA PRKAR2A | Axon guidance |
| KEGG:04611 | 0.00223741954427 | 0.3 | PRKACB PRKACG PRKACA | Platelet activation |
| KEGG:04919 | 0.00236002946355 | 0.3 | PRKACB PRKACG PRKACA | Thyroid hormone signaling pathway |
| GO:0065009 | 0.00240931876165 | 0.9 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | regulation of molecular function |
| GO:0120025 | 0.00242966867482 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | plasma membrane bounded cell projection |
| REAC:R-HSA-8854518 | 0.0024377661961 | 0.3 | AKAP9 PRKACA PRKAR2B | AURKA Activation by TPX2 |
| GO:0048878 | 0.00255610616797 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | chemical homeostasis |
| GO:0042995 | 0.00260098182348 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | cell projection |
| KEGG:04926 | 0.00282379100671 | 0.3 | PRKACB PRKACG PRKACA | Relaxin signaling pathway |
| KEGG:04728 | 0.00289455783846 | 0.3 | PRKACB PRKACG PRKACA | Dopaminergic synapse |
| KEGG:04915 | 0.0029664799332 | 0.3 | PRKACB PRKACG PRKACA | Estrogen signaling pathway |
| KEGG:04740 | 0.00311382505374 | 0.3 | PRKACB PRKACG PRKACA | Olfactory transduction |
| KEGG:04371 | 0.00311382505374 | 0.3 | PRKACB PRKACG PRKACA | Apelin signaling pathway |
| WP:WP4549 | 0.00322903412284 | 0.3 | AKAP5 PRKACA PRKAR1A | Fragile X Syndrome |
| KEGG:05012 | 0.00326589651874 | 0.3 | PRKACB PRKACG PRKACA | Parkinson disease |
| GO:0051247 | 0.0033296424371 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | positive regulation of protein metabolic process |
| GO:0019220 | 0.00335157729799 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | regulation of phosphate metabolic process |
| GO:0051174 | 0.00337363774884 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | regulation of phosphorus metabolic process |
| KEGG:04261 | 0.00350301853952 | 0.3 | PRKACB PRKACG PRKACA | Adrenergic signaling in cardiomyocytes |
| REAC:R-HSA-380270 | 0.00351048557362 | 0.3 | AKAP9 PRKACA PRKAR2B | Recruitment of mitotic centrosome proteins and complexes |
| REAC:R-HSA-380287 | 0.00351048557362 | 0.3 | AKAP9 PRKACA PRKAR2B | Centrosome maturation |
| KEGG:04062 | 0.00358449801405 | 0.3 | PRKACB PRKACG PRKACA | Chemokine signaling pathway |
| KEGG:04723 | 0.00375116727666 | 0.3 | PRKACB PRKACG PRKACA | Retrograde endocannabinoid signaling |
| KEGG:04140 | 0.0038363743889 | 0.3 | PRKACB PRKACG PRKACA | Autophagy - animal |
| REAC:R-HSA-70326 | 0.00392720107262 | 0.3 | PRKACB PRKACG PRKACA | Glucose metabolism |
| KEGG:04921 | 0.00401057678593 | 0.3 | PRKACB PRKACG PRKACA | Oxytocin signaling pathway |
| GO:0031399 | 0.00404486529803 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | regulation of protein modification process |
| REAC:R-HSA-2565942 | 0.00422239142849 | 0.3 | AKAP9 PRKACA PRKAR2B | Regulation of PLK1 Activity at G2/M Transition |
| KEGG:04934 | 0.00456410896629 | 0.3 | PRKACB PRKACG PRKACA | Cushing syndrome |
| GO:0008081 | 0.00459827964391 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | phosphoric diester hydrolase activity |
| REAC:R-HSA-5687128 | 0.00469205751434 | 0.3 | PRKACB PRKACG PRKACA | MAPK6/MAPK4 signaling |
| KEGG:04530 | 0.00495958625926 | 0.3 | PRKACB PRKACG PRKACA | Tight junction |
| KEGG:04310 | 0.00516546605377 | 0.3 | PRKACB PRKACG PRKACA | Wnt signaling pathway |
| REAC:R-HSA-380320 | 0.00519494891462 | 0.3 | AKAP9 PRKACA PRKAR2B | Recruitment of NuMA to mitotic centrosomes |
| REAC:R-HSA-4420097 | 0.00537015050344 | 0.3 | PRKACB PRKACG PRKACA | VEGFA-VEGFR2 Pathway |
| GO:0035556 | 0.00564722318304 | 0.9 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG AKAP11 PRKACA PRKAR2A | intracellular signal transduction |
| REAC:R-HSA-5620912 | 0.0061098807566 | 0.3 | AKAP9 PRKACA PRKAR2B | Anchoring of the basal body to the plasma membrane |
| KEGG:04020 | 0.00651897348671 | 0.3 | PRKACB PRKACG PRKACA | Calcium signaling pathway |
| REAC:R-HSA-194138 | 0.00691380356188 | 0.3 | PRKACB PRKACG PRKACA | Signaling by VEGF |
| GO:0034237 | 0.00737429365883 | 0.3 | AKAP9 PRKACA AKAP5 | protein kinase A regulatory subunit binding |
| KEGG:05034 | 0.00740600690315 | 0.3 | PRKACB PRKACG PRKACA | Alcoholism |
| WP:WP4223 | 0.0078484775429 | 0.3 | PRKACB PRKACG PRKACA | Ras Signaling |
| KEGG:04024 | 0.00794653028563 | 0.3 | PRKACB PRKACG PRKACA | cAMP signaling pathway |
| GO:0050790 | 0.00836489969518 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | regulation of catalytic activity |
| GO:0006468 | 0.00881354657989 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | protein phosphorylation |
| KEGG:04014 | 0.0100396314587 | 0.3 | PRKACB PRKACG PRKACA | Ras signaling pathway |
| KEGG:05203 | 0.0106972943022 | 0.3 | PRKACB PRKACG PRKACA | Viral carcinogenesis |
| KEGG:05205 | 0.0106972943022 | 0.3 | PRKACB PRKACG PRKACA | Proteoglycans in cancer |
| GO:0071901 | 0.0116266718166 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | negative regulation of protein serine/threonine kinase activity |
| REAC:R-HSA-162582 | 0.0120012589323 | 0.7 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKACG PRKACA PRKAR2A | Signal Transduction |
| KEGG:05166 | 0.012278133555 | 0.3 | PRKACB PRKACG PRKACA | Human T-cell leukemia virus 1 infection |
| GO:0031625 | 0.0122947591166 | 0.5 | PRKAR2B PRKACB PRKAR1A PRKAR2A PRKACA | ubiquitin protein ligase binding |
| GO:0034377 | 0.0123497091753 | 0.3 | PRKACB PRKACG PRKACA | plasma lipoprotein particle assembly |
| KEGG:05163 | 0.0132185144954 | 0.3 | PRKACB PRKACG PRKACA | Human cytomegalovirus infection |
| REAC:R-HSA-5621481 | 0.0142114325502 | 0.3 | PRKACB PRKACG PRKACA | C-type lectin receptors (CLRs) |
| KEGG:04714 | 0.0146119003934 | 0.3 | PRKACB PRKACG PRKACA | Thermogenesis |
| GO:0019932 | 0.015363215969 | 0.5 | PRKAR1B PRKAR2B PRKAR1A PRKAR2A PRKACA | second-messenger-mediated signaling |
| GO:0044389 | 0.0162974539613 | 0.5 | PRKAR2B PRKACB PRKAR1A PRKAR2A PRKACA | ubiquitin-like protein ligase binding |
| GO:0065005 | 0.0166711727856 | 0.3 | PRKACB PRKACG PRKACA | protein-lipid complex assembly |
| WP:WP382 | 0.0217644056226 | 0.3 | PRKACB PRKACG PRKACA | MAPK Signaling Pathway |
| HP:0003118 | 0.0228430052933 | 0.2 | PRKACA PRKAR1A | Increased circulating cortisol level |
| KEGG:04010 | 0.0264785085069 | 0.3 | PRKACB PRKACG PRKACA | MAPK signaling pathway |
| HP:0008221 | 0.0266406279253 | 0.2 | PRKACA PRKAR1A | Adrenal hyperplasia |
| GO:0019935 | 0.0285805055799 | 0.4 | PRKAR1B PRKAR2B PRKAR2A PRKAR1A | cyclic-nucleotide-mediated signaling |
| REAC:R-HSA-1266738 | 0.0362954800846 | 0.5 | AKAP5 PRKACB PRKACG PRKACA PRKAR2A | Developmental Biology |
| HP:0001065 | 0.0397718001983 | 0.2 | PRKACA PRKAR1A | Striae distensae |
| GO:0016310 | 0.0405245438553 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | phosphorylation |
| KEGG:05165 | 0.047087803646 | 0.3 | PRKACB PRKACG PRKACA | Human papillomavirus infection |
| GO:0019899 | 0.0472988777882 | 0.8 | PRKAR2B PRKAR1B AKAP5 PRKACB PRKAR1A PRKAR2A AKAP11 PRKACA | enzyme binding |
| REAC:R-HSA-69275 | 0.0480244330629 | 0.3 | AKAP9 PRKACA PRKAR2B | G2/M Transition |
| REAC:R-HSA-68877 | 0.0487734821247 | 0.3 | AKAP9 PRKACA PRKAR2B | Mitotic Prometaphase |
| REAC:R-HSA-5617833 | 0.0487734821247 | 0.3 | AKAP9 PRKACA PRKAR2B | Cilium Assembly |
| REAC:R-HSA-453274 | 0.0495300972407 | 0.3 | AKAP9 PRKACA PRKAR2B | Mitotic G2-G2/M phases |
| WP:WP1403 | 0.0499379210576 | 0.2 | PRKACG PRKACB | AMP-activated Protein Kinase (AMPK) Signaling |
| GO:0071310 | 0.0499948790616 | 0.8 | PRKAR2B PRKAR1B PRKACB PRKAR1A PRKAR2A AKAP9 PRKACA PRKACG | cellular response to organic substance |
Edges
| Protein 1 | Protein 2 | Score | Precision | Evidence |
|---|---|---|---|---|
| PRKAR2A | PRKACA | 1.0 | 0.949 | hein_WMM bioplex_WMM Guru youn_WMM hein (PRKAR2A) Malo gupta_WMM fraction |
| PRKACB | PRKAR1A | 1.0 | 0.949 | hein_WMM bioplex (PRKACB,PRKAR1A) bioplex_WMM Guru hein (PRKACB) fraction |
| PRKAR1A | PRKAR1B | 1.0 | 0.949 | hein_WMM bioplex (PRKAR1A) bioplex_WMM |
| AKAP9 | PRKAR2B | 1.0 | 0.949 | hein_WMM bioplex (PRKAR2B) bioplex_WMM hein (PRKAR2B) |
| PRKACB | PRKAR2B | 1.0 | 0.949 | hein_WMM bioplex (PRKACB,PRKAR2B) bioplex_WMM youn_WMM hein (PRKAR2B) gupta_WMM |
| PRKAR2A | PRKAR2B | 1.0 | 0.949 | hein_WMM bioplex (PRKAR2B) bioplex_WMM youn_WMM hein (PRKAR2B) gupta_WMM |
| PRKACA | PRKAR2B | 0.999 | 0.949 | hein_WMM bioplex (PRKAR2B) bioplex_WMM youn_WMM hein (PRKAR2B) gupta_WMM |
| PRKAR1A | PRKACA | 0.998 | 0.945 | hein_WMM bioplex (PRKAR1A) bioplex_WMM Guru boldt fraction boldt_WMM |
| PRKACB | AKAP11 | 0.997 | 0.929 | hein_WMM bioplex (PRKACB) bioplex_WMM youn_WMM hein (PRKACB) |
| PRKACB | PRKACA | 0.993 | 0.918 | hein_WMM bioplex (PRKACB) bioplex_WMM youn_WMM hein (PRKACB) gupta_WMM |
| PRKACB | AKAP9 | 0.993 | 0.917 | hein_WMM bioplex (PRKACB) bioplex_WMM hein (PRKACB) |
| PRKACB | AKAP5 | 0.982 | 0.898 | hein_WMM bioplex (PRKACB) bioplex_WMM hein (AKAP5) gupta_WMM |
| PRKAR1A | PRKACG | 0.956 | 0.862 | bioplex (PRKACG,PRKAR1A) bioplex_WMM |
| PRKACB | PRKAR1B | 0.943 | 0.856 | hein_WMM bioplex (PRKACB) bioplex_WMM hein (PRKACB) |
| PRKAR2B | AKAP5 | 0.929 | 0.846 | bioplex (PRKAR2B) bioplex_WMM gupta_WMM |
| PRKACG | PRKAR2B | 0.907 | 0.83 | bioplex (PRKACG,PRKAR2B) bioplex_WMM |
| PRKACB | PRKAR2A | 0.737 | 0.738 | hein_WMM bioplex (PRKACB) bioplex_WMM youn_WMM hein (PRKACB,PRKAR2A) gupta_WMM |
| PRKAR2A | AKAP5 | 0.523 | 0.633 | hein_WMM bioplex_WMM hein (AKAP5) gupta_WMM |
| PRKAR1A | AKAP11 | 0.516 | 0.631 | hein_WMM bioplex (PRKAR1A) bioplex_WMM youn_WMM boldt_WMM |
| AKAP11 | PRKAR2B | 0.5 | 0.621 | bioplex (PRKAR2B) bioplex_WMM youn_WMM gupta_WMM |
| PRKACA | AKAP5 | 0.185 | 0.439 | hein_WMM bioplex_WMM hein (AKAP5) gupta_WMM |
| PRKACG | AKAP5 | 0.09 | 0.356 | bioplex (PRKACG) bioplex_WMM |
| PRKAR2A | AKAP9 | 0.078 | 0.352 | hein_WMM bioplex (AKAP9) bioplex_WMM hein (PRKAR2A) |
| PRKACB | PRKACG | 0.047 | 0.29 | bioplex (PRKACB,PRKACG) bioplex_WMM |
| AKAP9 | PRKACG | 0.026 | 0.224 | bioplex (PRKACG) bioplex_WMM |
| PRKACA | PRKACG | 0.026 | 0.218 | bioplex (PRKACG) bioplex_WMM |
| PRKAR2B | PRKAR1B | 0.024 | 0.21 | bioplex (PRKAR2B) bioplex_WMM |
| PRKAR2A | PRKACG | 0.018 | 0.181 | bioplex (PRKACG) bioplex_WMM |
| PRKACG | PRKAR1B | 0.018 | 0.177 | bioplex (PRKACG) bioplex_WMM |
| AKAP11 | PRKAR1B | 0.017 | 0.164 | hein_WMM bioplex_WMM WMM_only |
| PRKACA | AKAP9 | 0.015 | 0.142 | hein_WMM bioplex (AKAP9) bioplex_WMM boldt_WMM |
| PRKAR1A | PRKAR2B | 0.015 | 0.138 | bioplex (PRKAR2B) bioplex_WMM |
| PRKACA | AKAP11 | 0.011 | 0.148 | hein_WMM bioplex_WMM youn_WMM WMM_only |
| AKAP9 | AKAP5 | 0.011 | 0.139 | bioplex_WMM WMM_only |
| AKAP5 | PRKAR1B | 0.01 | 0.118 | bioplex_WMM WMM_only |
| PRKAR1A | AKAP5 | 0.01 | 0.118 | bioplex_WMM WMM_only |
| AKAP11 | PRKACG | 0.01 | 0.118 | bioplex (PRKACG) bioplex_WMM |
| PRKAR1A | AKAP9 | 0.009 | 0.108 | hein_WMM bioplex_WMM WMM_only boldt_WMM |
| PRKAR2A | PRKAR1B | 0.009 | 0.095 | hein_WMM bioplex_WMM WMM_only |
| AKAP9 | PRKAR1B | 0.008 | 0.089 | hein_WMM bioplex_WMM WMM_only |
| AKAP11 | AKAP5 | 0.008 | 0.086 | bioplex_WMM WMM_only |
| PRKAR2A | AKAP11 | 0.008 | 0.035 | hein_WMM bioplex_WMM youn_WMM WMM_only |
| AKAP11 | AKAP9 | 0.008 | 0.034 | hein_WMM bioplex_WMM WMM_only |
| PRKAR1A | PRKAR2A | 0.006 | 0.005 | hein_WMM bioplex (PRKAR1A) bioplex_WMM hein (PRKAR2A) treiber_WMM |
| PRKACA | PRKAR1B | 0.005 | 0.01 | hein_WMM bioplex_WMM Guru fraction |
Images
Click to enlarge
Complex HuMAP2_04684 has an average edge precision of 0.472 which is ranked 2677 out of all 6965 complexes.
Related Complexes